BioRestorative Therapies (BRTX) Insider Trading & Ownership $1.55 +0.10 (+6.90%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Insider Trades Stock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC Filings BioRestorative Therapies (OTCMKTS:BRTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage25.50%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$1.03 MNumber OfInsiders Selling(Last 3 Years)0 Get BRTX Insider Trade Alerts Want to know when executives and insiders are buying or selling BioRestorative Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BRTX Insider Buying and Selling by Quarter Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover BioRestorative Therapies Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/27/2023Dale BroadrickMajor ShareholderBuy1,000$2.80$2,800.00 7/25/2023Lance AlstodtCEOBuy4,200$2.44$10,248.00 3/31/2023Francisco SilvaVPBuy747$3.56$2,659.32 2/22/2023Dale BroadrickMajor ShareholderBuy6,000$2.86$17,160.00 2/1/2023Lance AlstodtCEOBuy400$3.10$1,240.00 1/27/2023Lance AlstodtCEOBuy200$3.01$602.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/20/2023Lance AlstodtCEOBuy200$3.13$626.00 1/18/2023Lance AlstodtCEOBuy400$3.11$1,244.00 1/9/2023Lance AlstodtCEOBuy100$3.08$308.00 12/23/2022Lance AlstodtCEOBuy300$3.01$903.00 12/7/2022Lance AlstodtCEOBuy1,800$2.99$5,382.00 11/21/2022Francisco SilvaVPBuy943$2.62$2,470.66 11/18/2022Lance AlstodtCEOBuy1,000$2.88$2,880.00 10/11/2022Francisco SilvaVPBuy806$3.69$2,974.14 9/23/2022Dale BroadrickMajor ShareholderBuy300$2.83$849.00 9/22/2022Lance AlstodtCEOBuy200$2.92$584.00 8/29/2022Francisco SilvaVPBuy2,816$3.21$9,039.36 8/26/2022Francisco SilvaVPBuy2,600$3.35$8,710.00 7/12/2022Dale BroadrickMajor ShareholderBuy900$2.97$2,673.00 7/12/2022Lance AlstodtCEOBuy700$2.95$2,065.00 7/6/2022Dale BroadrickMajor ShareholderBuy100$3.38$338.00 6/30/2022Dale BroadrickMajor ShareholderBuy1,900$3.08$5,852.00 6/30/2022Lance AlstodtCEOBuy1,100$3.10$3,410.00 6/21/2022Dale BroadrickMajor ShareholderBuy100$3.68$368.00 6/17/2022Dale BroadrickMajor ShareholderBuy600$3.80$2,280.00 6/15/2022Dale BroadrickMajor ShareholderBuy1,200$3.72$4,464.00 6/15/2022Lance AlstodtCEOBuy700$3.68$2,576.00 6/15/2022Robert Eugene KristalCFOBuy194$3.61$700.34 6/13/2022Dale BroadrickMajor ShareholderBuy1,300$3.92$5,096.00 6/13/2022Lance AlstodtCEOBuy200$3.95$790.00 6/10/2022Dale BroadrickMajor ShareholderBuy600$4.23$2,538.00 6/8/2022Dale BroadrickMajor ShareholderBuy2,400$4.33$10,392.00 6/8/2022Lance AlstodtCEOBuy100$4.28$428.00 6/7/2022Robert Eugene KristalCFOBuy200$4.56$912.00 6/6/2022Dale BroadrickMajor ShareholderBuy3,000$4.93$14,790.00 6/2/2022Dale BroadrickMajor ShareholderBuy1,000$4.69$4,690.00 6/1/2022Lance AlstodtCEOBuy200$4.60$920.00 5/26/2022Dale BroadrickMajor ShareholderBuy4,950$3.51$17,374.50 5/26/2022Lance AlstodtCEOBuy2,700$3.52$9,504.00 5/2/2022Lance AlstodtCEOBuy400$3.95$1,580.00 This Indicator called BOTH NVDA rallies (Ad)Rarely would I label something as “the best” But in this rare instance, I believe this is THE BEST indicator for trading Nvida’s stock. Except, it’s not another tech stock like Nvidia. But rather a stock hiding in broad daylight… So, if you’d like to see what this stock is… Click this link here. 4/8/2022Robert Eugene KristalCFOBuy7,600$5.71$43,396.00 4/5/2022Dale BroadrickMajor ShareholderBuy46,000$5.71$262,660.00 3/31/2022Dale BroadrickMajor ShareholderBuy10,700$4.72$50,504.00 3/29/2022Dale BroadrickMajor ShareholderBuy5,000$5.12$25,600.00 3/21/2022Dale BroadrickMajor ShareholderBuy10,000$4.35$43,500.00 3/9/2022Dale BroadrickMajor ShareholderBuy11,875$4.00$47,500.00 3/7/2022Dale BroadrickMajor ShareholderBuy24,392$4.43$108,056.56 3/3/2022Dale BroadrickMajor ShareholderBuy47,648$5.47$260,634.56 3/1/2022Dale BroadrickMajor ShareholderBuy2,270$5.55$12,598.50 1/24/2022Lance AlstodtCEOBuy1,470$3.40$4,998.00 1/5/2022Lance AlstodtCEOBuy2,000$3.85$7,700.00 (Data available from 1/1/2013 forward) BRTX Insider Trading Activity - Frequently Asked Questions Who is on BioRestorative Therapies's Insider Roster? The list of insiders at BioRestorative Therapies includes Dale Broadrick, Francisco Silva, Lance Alstodt, and Robert Eugene Kristal. Learn more on insiders at BRTX. What percentage of BioRestorative Therapies stock is owned by insiders? 25.50% of BioRestorative Therapies stock is owned by insiders. Learn more on BRTX's insider holdings. Which BioRestorative Therapies insiders have been buying company stock? The following insiders have purchased BRTX shares in the last 24 months: Dale Broadrick ($19,960.00), Francisco Silva ($2,659.32), and Lance Alstodt ($15,171.00). How much insider buying is happening at BioRestorative Therapies? Insiders have purchased a total of 13,547 BRTX shares in the last 24 months for a total of $37,790.32 bought. BioRestorative Therapies Key ExecutivesMr. Lance Alstodt (Age 53)Chairman of the Board, President & CEO Compensation: $954.17kMr. Robert Eugene Kristal (Age 56)Chief Financial Officer Compensation: $368.12kMr. Francisco J. Silva (Age 49)Chief Scientist, VP of Research & Development, Secretary and Director Compensation: $891.67kMr. Robert Paccasassi (Age 55)Vice President of Quality Assurance & Regulatory Compliance Compensation: $233.95kDr. Wayne J. Olan M.D.Clinical Director of Regenerative Disc & Spine Program and Member of Scientific Advisory Board More Insider Trading Tools from MarketBeat Related Companies Marpai Insider Trading Psychemedics Insider Trading Oncology Institute Insider Trading OpGen Insider Trading Ontrak Insider Trading Mangoceuticals Insider Trading ATI Physical Therapy Insider Trading CareMax Insider Trading Aclarion Insider Trading Better Therapeutics Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (OTCMKTS:BRTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioRestorative Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
